| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/07/2013 | WO2013033518A1 Methods for treating properdin-related diseases or disorders |
| 03/07/2013 | WO2013033370A1 Prevention and treatment of thrombosis in medically ill patients |
| 03/07/2013 | WO2013031930A1 Imine derivative |
| 03/07/2013 | WO2013011166A3 Use of a composition in the production of a dialysis solution for the treatment of cerebrovascular diseases by means of peritoneal dialysis |
| 03/07/2013 | WO2012156537A9 Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of thrombosis and cardiovascular diseases |
| 03/07/2013 | US20130059913 Composition for amelioration of hypoalbuminemia |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059822 Arylfluorophosphate Inhibitors of Intestinal Apical Membrane Sodium/Phosphate Co-Transport |
| 03/07/2013 | US20130059820 Inositol pyrophosphates, and methods of use thereof |
| 03/07/2013 | US20130059816 Compositions and methods for treatment of autoimmune and other disease |
| 03/07/2013 | US20130059810 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059809 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059806 Epigenetic co-repressors of the gamma-globin gene and methods of using same |
| 03/07/2013 | US20130059785 Gene and Polypeptide Sequences |
| 03/07/2013 | US20130059783 Compositions and methods for expanding bfu-e cells |
| 03/07/2013 | US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin |
| 03/07/2013 | US20130059000 Oral delivery for hemoglobin based oxygen carriers |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058949 Antagonists of il-6 to prevent or treat thrombosis |
| 03/07/2013 | US20130058929 Fusion proteins for inhibition and dissolution of coagulation of thrombi |
| 03/07/2013 | US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/07/2013 | US20130058911 Reducing agent from microorganism belonging to genus bacillus and application for same |
| 03/07/2013 | US20130058905 Angiohematopoietic Progenitor Cells |
| 03/07/2013 | US20130058880 Film forming personal care compositions and methods |
| 03/07/2013 | US20130058866 N-pyrazole a2a receptor agonists |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2844464A1 Methods for treating properdin-related diseases or disorders |
| 03/06/2013 | EP2565269A1 High-purity soluble thrombomodulin and method for producing same |
| 03/06/2013 | EP2563403A1 Conjugated blood coagulation factor viia |
| 03/06/2013 | EP2563402A1 Conjugated blood coagulation factor viii |
| 03/06/2013 | EP2563369A2 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| 03/06/2013 | CN102959075A Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102952839A Method for extracting Tuna collagen solution and product thereof |
| 03/06/2013 | CN102952726A Fleece flower root blood-nourishing wine and brewing method |
| 03/06/2013 | CN102952723A Glossy privet fruit blood nourishing wine and brewing method |
| 03/06/2013 | CN102952719A Ginseng blood-nourishing wine and brewing method |
| 03/06/2013 | CN102952718A Barbary wolfberry fruit blood nourishing wine and preparation method thereof |
| 03/06/2013 | CN102952717A Motherwort fruit blood nourishing wine and method for making same |
| 03/06/2013 | CN102952707A Potentilla discolor hematochezia health-care wine |
| 03/06/2013 | CN102952698A Preparation method of epimedium-pilose asiabell root kidney-tonifying wine |
| 03/06/2013 | CN102952666A Blood replenishing, skin nourishing and beauty maintaining wine |
| 03/06/2013 | CN102952202A Preparation method and use of ultralow-molecular weight heparin sodium |
| 03/06/2013 | CN102949754A Uterine cavity hemostasis anti-adhersion temperature-sensitive gel and preparation method thereof |
| 03/06/2013 | CN102949722A Novel pharmaceutical composition based on p38 inhibitor and cell growth factor |
| 03/06/2013 | CN102949706A In-situ hemostatic containing desmopressin |
| 03/06/2013 | CN102949686A Buffalo horn yingfen cooling and detoxifying tablet |
| 03/06/2013 | CN102949636A Traditional Chinese medicine for treating cirrhosis with ascites |
| 03/06/2013 | CN102949617A Pill for dredging and dissolving thrombus |
| 03/06/2013 | CN102949589A Pure traditional Chinese medicine heal-care product granule for nourishing blood and growing hair and preparation method thereof |
| 03/06/2013 | CN102949584A Traditional Chinese medicine composition for treating purpura |
| 03/06/2013 | CN102949554A Traditional Chinese medicinal composite for treating anaphylactoid purpura |
| 03/06/2013 | CN102949544A Chinese medicinal composition for specifically treating swelling of hands and feet of hemiplegic patients |
| 03/06/2013 | CN102949519A Pure Chinese medical composition for tonifying qi and blood and preparation method thereof |
| 03/06/2013 | CN102949357A Prasugrel hydrobromide tablet |
| 03/06/2013 | CN102657677B Glycerin fructose sodium chloride injection |
| 03/06/2013 | CN102552148B Potassium chloride liposome injection |
| 03/06/2013 | CN102525910B Process for preparing penehyclidine hydrochloride injection |
| 03/06/2013 | CN102429930B Compound fermented cordyceps fungus powder and baicalin combined drug, |
| 03/06/2013 | CN102218058B Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy |
| 03/06/2013 | CN102205113B Novel application of Jingzhaotoxin |
| 03/06/2013 | CN101785581B Smoking-cessation and health-care cigarette holders and using method thereof |
| 03/06/2013 | CN101759544B Novel chalcone compound and preparation method and application thereof |
| 03/06/2013 | CN101443004B Formulations and methods for vascular permeability-related diseases or conditions |
| 03/06/2013 | CN101374540B Purpose of TPO peptide compound and medicament composition for treating anaemia |
| 03/05/2013 | US8389043 Preparation for restenosis prevention |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 02/28/2013 | WO2013026118A1 Ready-to-use electrolyte formulation, ready-to-use bag, kit, uses and method for treating kidney failure |
| 02/28/2013 | WO2012174480A3 Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme |
| 02/28/2013 | WO2012166611A3 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| 02/28/2013 | WO2012156531A9 Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of inflammatory diseases or conditions |
| 02/28/2013 | US20130053446 Pharmaceutical preparations having individualized dosage and structure |
| 02/28/2013 | US20130053438 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053402 Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053393 Methods and compositions for treating peripheral vascular disease |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053332 Use |
| 02/28/2013 | US20130053320 Treatment of anemia by adnp and adnf polypeptides |
| 02/28/2013 | US20130053318 Modulating aquaporins with relaxin |
| 02/28/2013 | US20130053304 Glucagon-like peptide-1 analogues and uses thereof |
| 02/28/2013 | US20130053301 Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| 02/28/2013 | US20130052354 Evaporation operative materials having low environmental impact |
| 02/28/2013 | US20130052262 Dabigatran etexilate-containing oral pharmaceutical composition |
| 02/28/2013 | US20130052258 Polypeptides and uses thereof |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052169 Stem cell bank for personalized medicine |
| 02/28/2013 | US20130052142 Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 02/28/2013 | CA2846494A1 Compounds for use in boosting coagulation |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2560966A2 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/27/2013 | EP2560674A2 Nanoparticle targeting to ischemia for imaging and therapy |
| 02/27/2013 | EP2560668A1 Methods of treating glucose metabolism disorders |
| 02/27/2013 | EP2560661A2 Use of the modified polysaccharides for heparin neutralization |